PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
September 24, 2025Cancer ResearchOpen Access

CRB2 Activates an Epigenetic Axis to Promote Ferroptosis in Head and Neck Squamous Cell Carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

DZDiekuo ZhangJHJunli HuGZGangcai Zhu

Discussion

Loading...

Member takes

Overview

CRB2 modulates ferroptosis in HNSCC, suggesting potential therapeutic interventions for cancer treatment.

Key Points

  • CRB2 activation promotes ferroptosis in head and neck squamous cell carcinoma, enhancing cancer cell death.
  • Elevated CRB2 levels correlated with better patient prognosis and sensitivity to ferroptosis-inducing agents.
  • Study reveals that CRB2 regulates SLC7A11 through histone methylation, impacting ferroptosis.
  • Mechanistically, CRB2 facilitates degradation of LSD1, increasing H4K20me2 levels and promoting ferroptosis.

Cite This Study

Zhang et al. (2025) studied this question.

synapsesocial.com/papers/68d6e16f8b2b6861e4c3fff2https://doi.org/10.1158/0008-5472.can-24-3866
View Full Paper
Ask AI
Bookmark
Share